tldrdailynews.com logo

"FDA Approves Groundbreaking Cellular Therapy for Metastatic Melanoma"

1 min read
Source: FDA.gov
"FDA Approves Groundbreaking Cellular Therapy for Metastatic Melanoma"
Photo: FDA.gov
TL;DR

The FDA has approved Amtagvi, the first cellular therapy for adult patients with unresectable or metastatic melanoma that has been previously treated with other therapies. Amtagvi is a tumor-derived autologous T cell immunotherapy composed of a patient’s own T cells, and it has shown promising results in clinical trials. However, patients receiving this treatment may experience severe adverse reactions, and close monitoring is necessary.

Topics:businesshealth#amtagvi#cancer-treatment#cellular-therapy#fda#health#melanoma
Share this article
  1. FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma  FDA.gov
  2. FDA approves groundbreaking treatment for advanced melanoma  NBC News
  3. Camden woman cancer-free after being 1st patient for new FDA approved cancer treatment  CBS Philly
  4. FDA Approves First Cellular Therapy for Metastatic Melanoma  Medscape
  5. FDA Approves First Cellular Treatment For Advanced Melanoma  Forbes

Want the full story? Read the original reporting

Read on FDA.gov